1. Home
  2. ELTX vs OESX Comparison

ELTX vs OESX Comparison

Compare ELTX & OESX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.52

Market Cap

45.6M

Sector

Health Care

ML Signal

N/A

Logo Orion Energy Systems Inc.

OESX

Orion Energy Systems Inc.

N/A

Current Price

$12.75

Market Cap

49.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
OESX
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
49.7M
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
ELTX
OESX
Price
$1.52
$12.75
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$13.00
★ $36.00
AVG Volume (30 Days)
★ 305.0K
37.2K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
N/A
★ 0.27
Revenue
$2,301,000.00
★ $86,306,000.00
Revenue This Year
N/A
$17.95
Revenue Next Year
N/A
$10.38
P/E Ratio
★ N/A
$48.43
Revenue Growth
N/A
★ 8.26
52 Week Low
$1.25
$8.58
52 Week High
$16.00
$31.65

Technical Indicators

Market Signals
Indicator
ELTX
OESX
Relative Strength Index (RSI) 40.97 27.08
Support Level $1.35 $8.98
Resistance Level $1.98 $21.13
Average True Range (ATR) 0.19 1.60
MACD 0.01 -0.46
Stochastic Oscillator 42.19 14.19

Price Performance

Historical Comparison
ELTX
OESX

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.

Share on Social Networks: